ストックスクリーナーアプリを入手
1,080.36
0.53%
5.68
アフターアワーズ：
1078.00
-2.36
-0.22%
前日終値:
$1,074.68
開ける：
$1076.4
24時間の取引高:
2.45M
Relative Volume:
0.68
時価総額：
$966.94B
収益：
$59.42B
当期純損益:
$18.41B
株価収益率:
53.43
EPS:
20.2197
ネットキャッシュフロー:
$6.44B
1週間 パフォーマンス:
+0.24%
1か月 パフォーマンス:
+3.27%
6か月 パフォーマンス:
+38.64%
1年 パフォーマンス:
+38.85%
1日の値動き範囲:
$1,052.08
$1,080.66
1週間の範囲:
$1,052.08
$1,085.50
52週間の値動き範囲:
$623.78
$1,111.99
Lilly Eli Co Stock (LLY) Company Profile
LLY を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LLY
Lilly Eli Co
|
1,080.36 | 961.86B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
207.35 | 498.60B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
229.31 | 403.83B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
138.54 | 264.54B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
106.45 | 261.26B | 63.90B | 19.05B | 13.05B | 7.5596 |
Lilly Eli Co Stock (LLY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-16 | アップグレード | Daiwa Securities | Neutral → Buy |
| 2025-12-15 | 繰り返されました | BofA Securities | Buy |
| 2025-12-15 | 繰り返されました | Goldman | Buy |
| 2025-11-13 | 開始されました | Scotiabank | Sector Outperform |
| 2025-11-10 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2025-10-20 | 繰り返されました | BMO Capital Markets | Outperform |
| 2025-10-14 | アップグレード | Erste Group | Hold → Buy |
| 2025-09-17 | ダウングレード | Berenberg | Buy → Hold |
| 2025-08-27 | アップグレード | HSBC Securities | Reduce → Hold |
| 2025-08-18 | ダウングレード | Daiwa Securities | Outperform → Neutral |
| 2025-08-07 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2025-06-05 | ダウングレード | Erste Group | Buy → Hold |
| 2025-04-28 | ダウングレード | HSBC Securities | Buy → Reduce |
| 2025-04-22 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-12-10 | 再開されました | BofA Securities | Buy |
| 2024-11-15 | 開始されました | Wolfe Research | Outperform |
| 2024-10-17 | 開始されました | Bernstein | Outperform |
| 2024-09-13 | 再開されました | Citigroup | Buy |
| 2024-08-12 | アップグレード | Deutsche Bank | Hold → Buy |
| 2024-02-21 | ダウングレード | DZ Bank | Buy → Hold |
| 2024-02-16 | 繰り返されました | Morgan Stanley | Overweight |
| 2023-12-21 | ダウングレード | Daiwa Securities | Buy → Outperform |
| 2023-11-09 | 開始されました | Deutsche Bank | Hold |
| 2023-10-20 | 再開されました | UBS | Buy |
| 2023-08-09 | アップグレード | Jefferies | Hold → Buy |
| 2023-07-26 | 繰り返されました | Citigroup | Buy |
| 2023-07-14 | 開始されました | HSBC Securities | Buy |
| 2023-05-24 | 繰り返されました | BofA Securities | Buy |
| 2023-05-24 | 繰り返されました | UBS | Buy |
| 2023-03-13 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-03-06 | 開始されました | Jefferies | Hold |
| 2023-02-15 | ダウングレード | Societe Generale | Hold → Sell |
| 2022-11-18 | 開始されました | Credit Suisse | Outperform |
| 2022-09-22 | アップグレード | UBS | Neutral → Buy |
| 2022-05-23 | 開始されました | SVB Leerink | Outperform |
| 2022-04-06 | 再開されました | Morgan Stanley | Overweight |
| 2022-03-10 | 開始されました | Daiwa Securities | Outperform |
| 2022-01-21 | アップグレード | DZ Bank | Hold → Buy |
| 2022-01-03 | 繰り返されました | Bernstein | Mkt Perform |
| 2021-12-17 | 開始されました | Goldman | Neutral |
| 2021-12-16 | 繰り返されました | BMO Capital Markets | Outperform |
| 2021-12-16 | 繰り返されました | BofA Securities | Buy |
| 2021-12-09 | 再開されました | Wells Fargo | Equal Weight |
| 2021-11-19 | 開始されました | BMO Capital Markets | Outperform |
| 2021-10-11 | アップグレード | Berenberg | Hold → Buy |
| 2021-09-29 | アップグレード | Citigroup | Neutral → Buy |
| 2021-08-05 | アップグレード | DZ Bank | Hold → Buy |
| 2021-07-27 | 再開されました | Truist | Buy |
| 2021-06-24 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2021-01-19 | アップグレード | Mizuho | Neutral → Buy |
| 2020-12-10 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2020-11-10 | 再開されました | Bernstein | Mkt Perform |
| 2020-09-29 | 開始されました | Berenberg | Hold |
| 2020-09-03 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-06-16 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-04-21 | ダウングレード | UBS | Buy → Neutral |
| 2020-04-09 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-02-06 | 開始されました | Mizuho | Neutral |
| 2019-12-18 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2019-10-17 | 再開されました | BofA/Merrill | Buy |
| 2019-05-28 | 開始されました | Goldman | Buy |
| 2019-04-24 | アップグレード | Edward Jones | Hold → Buy |
| 2019-04-11 | ダウングレード | Guggenheim | Buy → Neutral |
| 2019-03-12 | 開始されました | JP Morgan | Overweight |
| 2019-01-23 | 開始されました | UBS | Buy |
| 2018-11-26 | ダウングレード | Citigroup | Buy → Neutral |
| 2018-10-31 | アップグレード | Credit Suisse | Underperform → Neutral |
| 2018-10-09 | 開始されました | Guggenheim | Buy |
| 2018-10-01 | 繰り返されました | SunTrust | Buy |
| 2018-09-26 | 再開されました | JP Morgan | Overweight |
すべてを表示
Lilly Eli Co (LLY) 最新ニュース
Should FlyteHealth’s Employer Obesity Partnership Shape the GLP-1 Narrative for Eli Lilly (LLY) Investors? - Yahoo Finance UK
How Trump Moved Stocks In 2025: Crypto, Drones, Health Care Sectors - Benzinga
Eli Lilly stock ends higher to start 2026 as traders eye JPM conference, earnings - ts2.tech
Quattro Financial Advisors LLC Acquires New Position in Eli Lilly and Company $LLY - MarketBeat
Brown Miller Wealth Management LLC Buys 3,620 Shares of Eli Lilly and Company $LLY - MarketBeat
Bourgeon Capital Management LLC Purchases 10,676 Shares of Eli Lilly and Company $LLY - MarketBeat
Eli Lilly and Company $LLY Shares Bought by Altfest L J & Co. Inc. - MarketBeat
Eli Lilly Shares Gain on Analyst Praise and Strategic Pricing Moves - AD HOC NEWS
Eli Lilly, Oracle, Home Depot, Canopy, Rocket Lab Insider Shake-Up - TipRanks
Sterling Investment Counsel LLC Buys 1,793 Shares of Eli Lilly and Company $LLY - MarketBeat
Silver Oak Securities Incorporated Has $3.32 Million Stock Position in Eli Lilly and Company $LLY - MarketBeat
Mattern Capital Management LLC Buys 3,673 Shares of Eli Lilly and Company $LLY - MarketBeat
Financial Consulate Inc. Invests $938,000 in Eli Lilly and Company $LLY - MarketBeat
Ninety One UK Ltd Purchases 11,668 Shares of Eli Lilly and Company $LLY - MarketBeat
Eli Lilly & Co.: How a 150-Year-Old Pharma Giant Became the World’s Hottest Growth Product - AD HOC NEWS
Behind the Scenes of Eli Lilly's Latest Options Trends - Benzinga
Institutional Investors Signal Confidence in Eli Lilly Amidst Market Crosscurrents - AD HOC NEWS
What Makes Eli Lilly And Co. (LLY) a Worthy Holding? - Insider Monkey
RVW Wealth LLC Invests $910,000 in Eli Lilly and Company $LLY - MarketBeat
Miracle Mile Advisors LLC Grows Stock Position in Eli Lilly and Company $LLY - MarketBeat
Celltrion completes acquisition of US Eli Lilly plant - theinvestor.co.kr
Burns J W & Co. Inc. NY Has $3.35 Million Stock Position in Eli Lilly and Company $LLY - MarketBeat
Celltrion Acquires Eli Lilly’s U.S. Facility with 680 billion won CMO Contract - Businesskorea
The Truth About Eli Lilly and Company: Why Everyone Is Betting Big On This Pharma Giant - AD HOC NEWS
Celltrion completes acquisition of Eli Lilly manufacturing facility in New Jersey - koreabiomed.com
Eli Lilly stock forecast 2026: Analysts see modest upside as pricing pressure bites - ts2.tech
Eli Lilly stock ends 2025 lower as 2026 drug-price shifts and GLP-1 pill race come into focus - ts2.tech
Smith Salley Wealth Management Has $14.84 Million Stake in Eli Lilly and Company $LLY - MarketBeat
Diversified Trust Co Boosts Stock Position in Eli Lilly and Company $LLY - MarketBeat
Ayrshire Capital Management LLC Has $7.42 Million Stock Position in Eli Lilly and Company $LLY - MarketBeat
Eli Lilly’s Strategic Gamble: Deep Price Cuts in China Challenge Profit Outlook - AD HOC NEWS
Eli Lilly stock dips after hours as Jardiance, Mounjaro price-cut headlines land into 2026 - ts2.tech
Stock Quote & Chart | Eli Lilly and Company - Eli Lilly
Could This Potential Move Boost Eli Lilly's Prospects? - AOL.com
Triangle biotech backed by Eli Lilly files to go public - The Business Journals
Segment Wealth Management LLC Buys 10,042 Shares of Eli Lilly and Company $LLY - MarketBeat
Simplify Asset Management Inc. Sells 4,453 Shares of Eli Lilly and Company $LLY - MarketBeat
Mirova US LLC Has $290.45 Million Stock Holdings in Eli Lilly and Company $LLY - MarketBeat
Eli Lilly’s Strategic Pivot: A Price War in China for Market Dominance - AD HOC NEWS
Eli Lilly Engages in Strategic Price Competition Amid Record Valuation - AD HOC NEWS
Eli Lilly-backed Insilico eyes beyond pharma with new AI models - Nikkei Asia
Why Is Vanda Pharmaceuticals' (VNDA) Stock Trending Overnight? - Benzinga
AI Company Raises 2.3 Billion Yuan for Listing with Eli Lilly and Temasek's Backing - 36Kr
The Truth About Eli Lilly and Company: Why Everyone on Wall Street Is Obsessed Right Now - AD HOC NEWS
Eli Lilly (LLY) Moves Fast to Secure Lead in India's Obesity Drug Market - Finviz
Eli Lilly (LLY) Moves Fast to Secure Lead in India’s Obesity Drug Market - Insider Monkey
Novo and Lilly cut prices of weight-loss drugs in China - Reuters
Lilly Endowment Sells 3,593 Shares of Eli Lilly & Co - TradingView — Track All Markets
Eli Lilly and Novo Nordisk Shares Dip After Cut Obesity Drug Prices in China - GuruFocus
Eli Lilly’s Strategic Price Cut Intensifies Rivalry in Chinese Weight-Loss Market - AD HOC NEWS
Novo Nordisk and Eli Lilly Slash Obesity Drug Prices in China - Yahoo Finance UK
Lilly Eli Co (LLY) 財務データ
収益
当期純利益
現金流量
EPS
0.19%
大文字化:
|
ボリューム (24 時間):